De la Torre A, Ramírez Ibarguen A-F. Minimal Residual Disease in Myeloma in 2024: Where We are Today. Can Hematol Today [Internet]. 2024 Dec. 3 [cited 2024 Dec. 22];3(3):47–54. Available from: https://canadianhematologytoday.com/article/view/3-3-De_la_Torre_et_al